Protein kinase C-e (PKC-e) has been shown to increase growth and cause malignant transformation when overexpressed in NIH3T3 cells, whereas PKC-d reduced ®broblast growth. Two reciprocal chimeric proteins (PKC-ed and PKC-de were constructed by exchanging the regulatory and catalytic domains of PKC-d and -e and were stably overexpressed in NIH3T3 cells. Fibroblasts that overexpressed either chimera showed maximum cell density and morphology that were intermediate between cells overexpressing PKC-d and those that overexpressed PKC-e. Moreover, all lines that expressed chimeras were capable of anchorage-independent growth in the presence of TPA, which indicated that both the regulatory and catalytic domains of PKC-e could independently induce NIH3T3 transformation, although the combination of both domains, as found in PKC-e, was the most active form. In contrast, the translocation pattern and ability to induce tumors in nude mice was attributable to the catalytic domains exclusively. In particular, cells that expressed PKC-de retained PKC-e's full potency of tumorgenicity when injected into nude mice. In sum, our ®ndings not only reinforce the concept that only certain PKC isozymes contribute to carcinogenesis but also show that dierent domains of PKCs mediate the physiologically distinguishable events of transformation and tumorgenesis.
Introduction
Protein kinase C (PKC), a multigene family of phospholipid-dependent and diacylglycerol (DAG)-activated Ser/Thr protein kinases, is a key component in signal transduction. PKC isozymes are grouped into four classes: PKC-a, -b (-bI and -bII), -g as Ca 2+ dependent and phorbol ester-dependent`conventional' cPKCs; PCK-d, -e, -Z, -y as Ca 2+ -independent and phorbol ester-responsive`novel' nPKCs; PKC-z and -l as Ca 2+ -independent, phorbol ester-unresponsivè atypical' aPKCs; and PKC-m, a unique Ca 2+ -independent isoform. PKC-d and -e when overexpressed have been shown to have opposite eects on growth, morphology, anchorage-independence and tumorgenicity in CHO cells, mouse and rat ®broblasts (Watanabe et al., 1992; Mischak et al., 1993; Cacace et al., 1993) . PKC-d, upon overexpression, reduced the growth rate in the absence of TPA, and in the case of CHO cells, arrested the cells in the G2/M phase in the presence of TPA (Watanabe et al., 1992) . In contrast, overexpression of PKC-e in rodent ®broblasts stimulated cell proliferation, increased saturation density, induced anchorage-independent growth and caused tumors in nude mice (Mischak et al., 1993; Cacace et al., 1993) . The tumorgenic activity of PKC-e in rat and mouse ®broblasts has implicated PKC-e with an oncogenic potential (Cacace et al., 1993) . To determine which domains of PKC-d and -e are responsible for these isozyme-speci®c contributions to ®broblast transformation, we constructed a pair of chimeric cDNA-expressing vectors by swapping the regulatory and catalytic domains of PKC-d and -e. In a previous study, these constructs were introduced into 32D, a mouse promyelocytic cell line. In that system, the catalytic domain of PKC-d was found to contain the dominant determinants for mediating TPA-induced macrophage dierentiation (Wang et al., 1997) .
In the present study, we seek to identify which domains of PKC-d and -e mediate PKC isotype-speci®c eects in mouse ®broblasts relevant to cancer, speci®cally subcellular targeting, growth, transformation and tumorgenicity. The chimeric PKC-de and PKC-ed cDNAs were stably expressed in NIH3T3 cells and the properties of the chimera-producing lines were compared to those of cell lines that overexpressed either PKC-d or -e.
Results
Establishing PKC-overexpressing NIH3T3 lines with increased PKC activity As described previously, the chimeric PKCs were obtained by PCR, then cloned and sequenced. No point mutations were detected in either construct. Two mammalian expression vectors (pLTR and pMV7) were used, and the transfected cells were selected in medium containing either mycophenolic acid plus HAT (hypoxanthine, aminopterin and thymidine) or G418, as appropriate. Resistant clones were picked randomly after each transfection and examined for PKC protein expression by Western blot analysis. Two cell lines with dierent levels of expression of each PKC chimera were selected for functional analysis. Western blot analysis probing with anti PKC-d (C-terminal) antiserum showed that chimeric PKC-ed was expressed at high levels in the cloned line ed-L1, expressing pLTRed, and at slightly lower levels in the bulk culture edMpool, expressing pMV7ed. PKC-de was detected at high levels in clone de-M1, and at low levels in clone de-M2, both expressing pMV7de, when hybridized with anti PKC-e (C-terminal) antiserum (Figure 1 ). Previously characterized cell lines that overexpressed either PKC-d (d-L2) and PKC-e (e-L2) (Mischak et al., 1993) , and bulk cultures of NIH3T3 cells transfected with pLTR and pMV7 empty vectors, named Lpool and Mpool, respectively, were used as controls (Figure 1) .
To demonstrate that the PKCs overexpressed in the selected clones were functional, the PKC kinase assay was performed on all cell lines. As expected, all PKC overexpressers showed increased kinase activities in comparison to 3T3 alone and to 3T3 containing the empty vectors (Table 1) .
Morphology and maximum cell density of PKC-and chimera-expressing cells with and without TPA treatment Morphologically, in the absence of TPA, d-L2 cells were larger and¯atter than e-L2, with long cytoplasmic processes, and attached ®rmly to the surface of the culture plates (Figure 2 ). The morphologies of the cells that expressed chimeras exhibited morphological characteristics that were intermediate between the lines that overexpressed PKC-d and PKC-e. Upon TPA treatment, the two chimera expressers with the higher protein levels showed dierent features: ed-L1 most resembled TPA-treated d-L2 cells, while de-M1 displayed features similar to those of the TPA-treated e-L2 cells (Figure 2 ).
The maximum cell densities of these cells (Table 2 ) re¯ected the morphological patterns of the cell lines in the absence of TPA (Figure 2 ). The number of e-L2 cells after 4 days of culture in con¯uence was 10 times higher than that of d-L2, while both chimeraexpressing lines exhibited intermediate saturation densities 2 ± 3-fold lower than that of e-L2 but 4 ± 5-fold higher than that of d-L2 (Table 2 ).
The subcellular relocation of chimeric PKCs in comparison to PKC-d and PKC-e in response to TPA treatment Activation of classical and novel PKCs by TPA results in translocation of PKC from the cytosol to dierent subcellular locations (Goodnight et al., 1995) . We examined the translocation pattern of PKC-d, -e and chimera overexpressers using immuno¯uorescent staining after treating the cells with 100 nM TPA for 10 min, 1 h or 4 h. To dierentiate overexpressed PKC-ed from endogenous PKC-d, an antibody against the N-terminus of PKC-e was used to localize PKC-ed. As illustrated in Figure 3 , PKC-d and PKC-ed, showed similar intracellular distribution patterns in the absence of TPA, present throughout the cytoplasm but concentrated in the perinuclear region. Upon treatment with Values for PKC enzymatic activity represent one (using a PKC substrate derived from the pseudosubstrate region of PKC-e) of three independent experiments employing dierent substrates with duplicate determinations of activity in each experiment. c PKC-d could be detected in NIH3T3 cells and all derivatives. Other PKCisoforms, chie¯y PKC-a, are also present in NIH3T3 cell derivatives (Mischak et al., 1993) TPA, both these overexpressers became round. Meanwhile, PKC-d and -ed immunoreactivities were redistributed to the plasma membrane with increased intensity around the nucleus. By 1 h, the immunoreactivity was exclusively located on/in the nucleus with little on the plasma membrane. The NIH3T3 ®broblasts used in our experiment exhibited minimal endogenous PKC-e (as shown in Figure 1b ). Thus an antibody toward the C-terminus of PKC-e could follow the location of both overexpressed PKC-e and -de without concern about confusion from endogenous PKC-e. In contrast to the PKC-d and -ed-overexpressing fibroblasts, cells that overexpressed PKC-e or PKC-de did not show a drastic morphological change, but both behaved similarly. In the absence of TPA, PKC-e immunoreactivity in both cell lines had an even and diused distribution throughout the cytoplasm with a relatively strong, punctate staining on/in the nucleus. Treatment with TPA slowly relocated some PKC-e and PKC-de to the plasma membrane so that a signi®cant amount of PKC-e and PKC-de translocation was seen after 4 h of TPA treatment. Even so, there was still a signi®cant amount of PKC-e and PKC-de remaining in the cytoplasm following the course of TPA treatment, and the staining on/in the nucleus seemed to remain unchanged in the presence of TPA (Figure 3 ).
Anchorage-independent growth of the PKC-and chimera-expressing cells with and without TPA treatment
The anchorage-independent growth of all cell lines was tested in 0.4% soft agar in growth medium (Table 2 and Figure 4 ). In repeated experiments, d-L2 did not grow in soft agar with or without TPA, while 1610 5 e-L2 cells gave rise to 41000 colonies, but only in the presence of TPA (Figure 4 ). In the case of the PKC chimeras, all de and ed chimeric PKC-expressing lines formed colonies in soft agar in the presence of TPA. It was striking that the two de lines also formed a lesser number of colonies in the absence of TPA. Both ed lines required TPA to display anchorage-independent growth. Moreover, a large number of de colonies were formed in the presence of TPA, and more soft agar colonies were produced by the chimeric lines with the higher levels of protein expression. In addition, there was a signi®cant dierence in the appearance of the colonies produced by dierent PKC-overexpressing lines. PKC-e and PKC-de soft agar colonies were loosely packed, with the colonies of PKC-e overexpresser reaching the largest size. The colonies of the two ed-expressing cell lines were similar to one another, but were both much denser than those of either PKC-e or PKC-de (Figure 4 ). The tumorgenicity of cells overexpressing PKC-d, -e and their chimeras PKC-overexpressing lines, along with empty vectorcontaining lines, were injected subcutaneously in nude mice at two doses: 1610 5 and 5610 5 cells/mouse. For 60 days after injection, the mice were monitored for the appearance and progression of tumors. As shown in Table 2 , both doses of cells that overexpressed PKC-e gave rise to tumors in 100% of the nude mice in less than 28 days with an average tumor doubling time of 9 days. Cells that overexpressed PKC-d showed no tumor formation within 60 days of injection. Among the chimeric PKC-expressing lines, only the PKC-de clone with higher expression levels induced tumors in nude mice with high eciency in less than 28 days. Tumors also arose from the less active PKC-de expresser, but only after 60 days. To con®rm that the tumors were derived from the expected PKC overexpressers, we used PCR to probe DNA from in vivo tumor tissues for the presence of PKC-d, -e, -de and -ed. Both PKC-e and PKC-de were detected in the tumor tissues dissected from the mice injected with the PKC-e and PKC-de overexpressers but not in control tumors (data not shown). Interestingly, de-M1 tumors progressed three times as fast as that of PKC-e tumors. This may re¯ect the higher level of protein expression in de-M1. The chimera-expressing lines that overexpressed PKC-ed gave virtually no tumors (only one out of 20 mice in ed-L1), although they did produce colonies in soft agar. It appears of special signi®cance to note that the induction of anchorage independence is not a good prediction of its ability to form tumors in nude mice.
Discussion
Both PKC-d and PKC-e are Ca 2+ -independent nPKCs, yet they have been shown to play diametrically opposed roles in NIH3T3 growth and transformation. It was expected that switching the structural domains between the two isozymes would allow a clear identi®cation of the structural elements that were responsible for the isotype-speci®c functions in ®broblasts. The d/e reciprocal PKC chimeras, when stably transfected into ®broblasts, produced protein levels that varied among cloned lines, but these levels remained relatively constant over the period of culture. Increased kinase activities were observed in all lines compared to empty vector-containing lines. These results indicated that the chimeric proteins are similar to native PKCs structurally and functionally, and they would be suitable for the subsequent isotype-speci®c functional analysis.
The ®rst and second parameters studied were the morphology and the maximum achievable cell density, which can be important indications of cell transformation. Cells that overexpressed PKC-d and PKC-e, d-L2 and e-L2, respectively, exhibited very dierent characteristics as described previously (Mischak et al., 1993) . Namely, the PKC-d overexpressers remained¯at and ®rmly attached to the culture vessel, whereas the PKC-e overexpressers looked more transformed ± rounder and less well attached to the plastic surface. Furthermore, the saturation density of e-L2 was 10 times higher than that of d-L2. In the absence of TPA treatment, the cell lines that expressed chimeric proteins exhibited morphological and growth features that were intermediate between those of d-L2 and e-L2. After TPA treatment dierences were observed in the morphology of the chimera expressers: ed-L1 resembled d-L2, and de-M1 looked more like e-L2, apparently re¯ecting the nature of their catalytic domains.
The third parameter studied was the site to which TPA induced translocation of the active enzymes, presumably the sites of their substrates. There was a great similarity between the translocation patterns of PKC-d in d-L2 and PKC-ed in ed-L1, namely to plasma membranes and nuclei in dramatically rounded cells with some spike-like processes. There was also a similarity between the translocation patterns of PKCe in e-L2 and PKC-de in de-M1, principally to the plasma membranes without apparent changes in distribution on/in nucleus or in the cytoplasm. These data indicate that the catalytic regions of PKC-d and PKC-e are major determinants of the isotype-speci®c translocations in response to TPA treatment. They are consistent with the reports in which Walker et al. swapped regulatory and catalytic domains of PKC-a and -bII, two Ca 2+ -dependent cPKCs, and demonstrated that the catalytic domain of PKC bII is responsible for its isotype-speci®c translocation to the nucleus (Walker et al., 1995) .
The fourth parameter studied was the ®broblasts' transformation as measured by growth in soft agar. The present results, which detected anchorage-independent growth of e-L2 but not d-L2, were consistent with the previous reports (Mischak et al., 1993; Cacace et al., 1993) . However, cells that expressed the d/e reciprocal chimeras exhibited dierences in anchorage-independent growth, with the PKC-de expressers showing greater colony-forming eciency than the PKC-ed expressers. It is apparent that the catalytic region of PKC-e is more potent than the regulatory region in bypassing the requirements for surface adhesion in the presence of TPA, although the presence of either region from PKC-e endowed the chimera with this ability. e-L2 possesses both regions from PKC-e and was the strongest inducer of soft agar colonies. Our previous results suggested that the catalytic domains were the major determinants of the PKC isozyme-speci®c functions (Wang et al., 1997) . This was con®rmed by the behaviors of PKC-de overexpressed in NIH3T3 cells, namely, the subcellular localization was similar to the wild-type PKC-e. Moreover, as with the overexpression of PKC-e, expression of PKC-de also endowed the cells with the ability to grow in soft agar and to form tumors in nude mice. However, it was quite unexpected to observe an eect of the PKC-ed expression on the growth of NIH3T3 in soft agar. The most likely explanation for this observation would be that the e regulatory domain binds to certain cellular components that recruit the ed chimeric protein to a location rich in PKC-e substrates. An unaccustomed abundance of this chimeric protein phosphorylates these substrates, mimicking PKC-e signaling and driving mitosis without surface attachment. These changes in translocation, although biologically relevant, may represent the behavior of a minor portion of PKC-ed and, therefore, might not be visible in the immunostaining. It is important to note that PKC-de-expressing cells formed soft agar colonies in the absence of TPA treatment, while PKC-ed did not. We postulate that this was caused by the high degree of spontaneous PKC activity in de chimeras in the absence of TPA due to the incomplete inhibition of the catalytic region of PKC-e by the heterologous pseudosubstrate domain of PKC-d and nearby regions.
The ®nal parameter, tumorgenicity, was viewed from three dierent perspectives: tumor-forming eciency, tumor doubling time and ®nal tumor volume. Distinctive dierences resulted from overexpression of the two types of reciprocal chimeras. A high eciency of tumor formation, short doubling time, and large ®nal tumor volume were seen in de-M1 cells ± a high level PKC-de-expressing line. However, neither high level expresser of PKC-ed (ed-L1 or ed-Mpool) produced tumors in nude mice (except one out of 20 mice in ed-L1). These results clearly indicated that the catalytic region of PKC-e was crucial for the tumorgenicity of PKC-e, while the contribution of the regulatory domain of PKC-e to tumorgenicity seemed negligible. These data are in agreement with a similar study using swapping mutants of PKC-a, PKC-d and PKC-e regulatory and catalytic domains (Acs et al., submitted).
The sequences in the PKC hinge region and catalytic domains have been found to mediate the nuclear targeting of PKC (James and Olson, 1992) . This led us to speculate that tumorgenicity may be mediated by partial translocation of PKC-e to the nucleus. In our study, the immuno¯uorescence staining of e-L2 and both cell lines that express PKC-de indicated a persistent, intense PKC-e immunoreactivity on/in the nucleus, regardless of TPA treatment. In contrast, PKC-d immunoreactivity in non-tumor-producing lines, d-L2 and ed-L1, was seen only in the perinuclear region rather than on/in nucleus in the absence of TPA. Nuclear events involving PKC-e have been demonstrated in the process of cell dierentiation and proliferation of rat pheochromocytoma PC12 cells and in PMA-induced megakaryocytic dierentiation of HEL cells . Although the present data and other reports suggest a nuclear event-related mechanism, more evidence is required to con®rm this hypothesis.
e-L2 produced tumors in nude mice in the absence of TPA treatment, while the growth in soft agar was dependent on TPA treatment. Thus the mechanisms invovled in in vivo tumorgenicity may dier from that in in vitro transformation. Distinct mitogenic signal transduction pathways that aect dierent aspects of neoplastic transformation have been described: the Ras/Raf/Mek/MAPK pathway that leads to uncontrolled growth and the Rac-and Rho-dependent pathways that lead to morphological transformation. Cooperation of both pathways is often required to achieve a fully transformed phenotype (Khosrav-Far et al., 1995; Prendergast et al., 1995) . In recent reports, PKC-e was found to stimulate the Ras kinase activity in COS cells and rodent ®broblasts in a growth factordependent pathway in vivo (Cacace et al., 1996; Cai et al., 1997) , and it was also able to activate Raf directly in vitro (Cai et al., 1997) . Therefore, the transforming signal transduction by overexpressed PKC-e may utilize one or both of these pathways.
It is possible that the transforming and/or the tumorgenic ability of PKC chimeras resulted from antagonizing the eect of endogenous PKC-d or amplifying the eect of endogenous PKC-e. However, in a preliminary study, NIH3T3 cells that overexpressed a dominant-negative (kinase-negative) PKCd-mutant or a similar PKC-e mutant exhibited no dierence morphologically and biologically from cells expressing the empty vector alone. This leads us to believe that the chimeras' eects were direct ones, not indirect, mediated by endogenous PKCs.
PKC-e must be expressed above a certain threshold to be transforming. In our study, the chimeric clones with the higher protein expression led to increased soft agar colonies, and higher levels of PKC-de were associated with enhanced tumorgenicity. Furthermore, in view of the unique behavior of the chimeric proteins, the determinants of isozyme-speci®c functions seemed to reside in speci®c functions of the structural domains rather than simply an eect of total PKC activity. This was most apparent in ed-L1 and ed-Mpool cells, in which even very high protein expression and enzymatic activity did not induce tumors in nude mice. Moreover, a low protein level in de-M2 decreased and postponed but did not abolish tumor formation.
In conclusion, this study documents the crucial role of the catalytic domain of two novel PKCs in cell transformation and tumorgenicity, and it shows that transformation and tumorgenicity associated with PKC as an oncogene can be uncoupled. Chimeric molecules in which smaller regions of the catalytic domain are swapped, together with eorts in identifying speci®c cellular targets/pathways for each isoforms, may give more detailed insight in PKC-generated events that lead to the conversion of a normal cell to a malignant cell.
Materials and methods

Construction of PKC-d and -e chimeras
The method used for preparing the chimeric constructs has been described in detail previously (Wang et al., 1997) . Brie¯y, we separately ampli®ed the regulatory and catalytic domains of PCK-d and -e from their cDNAs using Polymerase Chain Reaction (PCR) and a series of oligonucleotide primer pairs each of which includes a 21-mer that is present in the C3 region of both PKC-d and -e. Reciprocal chimeras of PKC-d and -e were generated using an overlap from the 21 bp region in C3 that is identical in the two isoforms and present in each of the ®rst-round PCR products. PCR products were initially cloned into a pBluescript SK+vector, sequenced, and ®nally recloned into the pLTR mammalian expression vector and the pMV7 retroviral vector at their EcoRI cloning sites. pLTR is a mammalian expression vector based on the Harvey sarcoma virus long terminal repeat, which contains the selectable marker xanthine-guanine phosphoribosyltransferase (Megidish and Mazurek, 1989) . pMV7 contains the Moloney leukemia virus (MLV) long terminal repeats and a selectable marker neo (Kirschmeier et al., 1988) .
Overexpression of PKCs in NIH3T3 cells
NIH3T3 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% fetal bovine serum, 4 mM L-glutamine, and 100 units/ml penicillin and 100 mg/ ml streptomycin. Cells were transfected with the expression vectors using Lipofectamine (Life Technologies, Inc. Gaithersburg, MD). Cells that were transfected with the constructs in the pLTR vector were selected for 2 weeks in medium supplemented with HAT (0.2 mM hypoxanthine, 0.4 mM aminopterin, and 16 mM thymidine) and 80 mM mycophenolic acid. Cells transfected with the constructs in the pMV7 vector were selected for 2 weeks in the presence of G418 (0.6 mg/ml). The presence of PKC as well as chimeric proteins and the levels of their expression were determined by Western blot analysis.
Western blot analysis
Cells growing in 6-well plates were washed three times with PBS and then collected with a cell scraper. Cell pellets were lysed in 400 ml of lysis buer (20 mM Tris-HCl, pH 7.5, 5 mM EGAT, 20 mg/ml leupeptin and 1 mM 4-(2-aminoethyl)benzenesulfonyl¯uoride) followed by a 10 s sonication. Protein content was measured by a microprotein assay using the BCA protein assay kit (Pierce, Rockford, IL) . Approximately 20 mg of lysates were mixed with equal volumes of 26SDS sample loading buer (60 mM Tris-HCl, pH 7.5, 2 mM EDTA, 10 mM 2-mercaptoethanol, 20% glycerol and 2% SDS), sizefractionated by electrophoresis on 1% SDS/10% polyacrylamide gels at 100 volts for 3 h, and then subjected to electrotransfer onto a nitrocellulose membrane at 100 volts for 30 min. Non-speci®c antibody binding was blocked by incubating the membrane in a 5% solution of dry milk in TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.5) at room temperature for 1 h. The blots were probed with rabbit antisera raised against the C-terminus of PKC-d (Research and Diagnostic Antibody, Berkeley, CA) or PKC-e (Life Technologies, Inc., Gaithersburg, MD) or with mouse monoclonal antibodies against the N-terminus of PKC-d or PKC-e (both from Transduction Labs., Lexington, KY). Goat anti-rabbit IgG and goat anti-mouse IgG coupled to Horseradish Peroxidase (HRP) were used as the secondary antibodies (Accurate Chemical and Scienti®c Corp., Westbury, NY). The immunoreactive bands were visualized using the LumiGLO Chemiluminescent Substrate Kit (Kirkegaard and Perry Lab., Gaithersburg, MD).
Protein kinase C assay 4610 6 cells were lysed in 100 ml of extraction buer (20 mM Tris-HCl, pH 7.4, 5 mM EGTA, 0.25 mM phenylmethylsulfonyl¯uoride and 20 mg/ml leupeptin) followed by sonication for 10 s. 10 ml of the lysates were added to 30 ml of assay mixture containing 50 mM TrisHCl, pH 7.4, 1 mM CaCl 2 , 50 mM myelin basic protein or esubstrate peptide (Life Technologies, Inc., Gaithersburg, MD), 80 mg/ml phosphatidylcholine, 20 mg/ml phosphatidylserine, 10 mM MgCl 2 , 1 mM TPA (LC Laboratories, Woburn, MA), 50 mM ATP and 1 mCi/assay [g 32 P]ATP (speci®c activity 6000 Ci/mmol, Amersham, Arlington Heights, IL). The reaction mixtures were incubated at 308C for 10 min and then chilled on ice. After addition of 10 ml of 40% trichloroacetic acid (48C), the reaction mixtures were spun in a microcentrifuge at 15 000 g and 25 ml of each supernatant was spotted onto phosphocellulose disks (Life Technologies, Inc., Gaithersburg, MD). The disks were washed three times in 0.5% phosphoric acid and three times in distilled water, and they were then counted in a liquid scintillation counter. The PKC activity was calculated as the total kinase activity measured in the presence of TPA minus the activity in the absence of TPA. Activity was expressed as counts per min of 32 P incorporated into substrate/mg protein.
Morphology and the measurement of maximum cell density
Cells seeded in 6-well plates were allowed to grow to 70% con¯uence. Photographs were generated for cells grown in the absence of TPA and for cells treated with 100 nM TPA for 10 h using an inverted light microscope under 1006 magni®cation. To measure the maximum cell density, 5610 5 cells were seeded in each well of a 6-well plate and allowed to grow to con¯uence. Medium was replenished every 2 days. Four days after con¯uence, the cells were trypsinized and the number of alive cells was determined using a hemocytometer. The results are presented in Table 2 as the mean+s.d. of cell numbers/ cm 2 from four separate experiments.
Immuno¯uorescent staining 5610 4 cells were seeded in 8-chamber slides and grown to about 70% con¯uence; 100 nM TPA was added and cells were incubated for 0, 10 min, 1 h or 4 h at 378C. After washing three times with ice-cold PBS, cells were ®xed with 100% methanol (7208C) for 15 min and permeabilized with PBS containing 0.25% Triton X-100 for 30 min on ice. The cells were probed with the same primary antibodies used in Western blotting at a dilution of 1 : 100. FITC-conjugated goat anti-rabbit IgG and FITCconjugated goat anti-mouse IgG were used as secondary antibodies. The hybridizations were carried out in immuno¯uorescence-blocking solution containing 5% non-fat dry milk plus 5% normal goat serum in PBS for 2 h at 48C. Finally, after washing, the slides were mounted with a SlowFade Antifade Kit (Molecular Probes, Inc., Eugene, OR), observed and photographed under ā uorescence microscope.
Soft agar assay
10 5 cells were mixed with 3 ml of 0.4% Noble agar (Sigma, St Louis, MO) in growth medium plus 0 or 30 nM TPA and overlaid above a layer of 0.6% agar in the same medium in one well of a 6-well plate. The cells were fed every 6 days by overlaying 2 ml of growth medium. The presence or absence of soft agar colonies in each well was scored and photographed after 14 days.
Tumorgenicity in nude mice
Groups of 10 mice were inoculated subcutaneously with one of two doses of PKC-overexpressing cells ± 1610 5 or 5610 5 cells/mouse. The development and progression of tumors were observed and recorded every 7 days over a period of 60 days or until sacri®ce. The tumor development was expressed as the tumor-forming eciency (ratio of the number of mice with tumors to the total number of mice), tumor doubling time (days) and ®nal tumor volume (mm 3 at the day of sacri®ce). The animals were sacri®ced when the tumors had grown to a considerable size but before the tumors caused visible distress to their hosts. The tumor tissues were dissected free of normal tissues, snap frozen in liquid nitrogen and stored at 7808C.
PCR analysis of the nude mice tumors
DNA was isolated from snap-frozen tumor tissues using SDS, Protease K, and phenol-chloroform extraction. Speci®c primers directed to the regulatory and catalytic domains of PKC-d, and -e were used to detect the presence of recombinant PKC-d, -e, -de and -ed in the genomic DNAs.
